bf/NASDAQ:BNTX_icon.jpeg

NASDAQ:BNTX

BioNTech SE

  • Stock

USD

Last Close

103.35

06/11 21:01

Market Cap

19.33B

Beta: 0.22

Volume Today

972.28K

Avg: 618.15K

PE Ratio

7.56

PFCF: 4.40

OverviewFinancialsAPI

    Description

    BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ hea...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    510152018-03-302019-06-302020-12-312022-05-092024-03-252025-05-16

    Revenue (Estimate*)

    1B2B3B4B5B6B2018-03-302019-06-302020-12-312022-05-092024-03-252025-05-16

    *Estimate based on analyst consensus